This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Bangkok Hospital Group Selects ClinicalKey To Enhance Medical Practice And Improve Patient Care

BANGKOK, September 16, 2013 /PRNewswire/ --

Elsevier's flagship 'clinical insight engine' provides fast, comprehensive and trusted medical content and answers to more than 500 clinicians

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that Bangkok Hospital and Bangkok Health Research Center, both part of the Bangkok Hospital Group, have selected Elsevier's ClinicalKey as their preferred online medical information resource to support clinical decision-making and medical research.

After implementation of ClinicalKey at these two facilities, the Bangkok Hospital Group, a leading operator hospital network throughout Southeast Asia, owned and operated by Bangkok Dusit Medical Services PC Ltd. (BDMS), expects to further roll out usage at other hospitals and medical facilities throughout Thailand.  

"In medical care and clinical research, quick access to the most current scientific information is critical for healthcare providers and researchers to deliver accurate and timely diagnosis and innovation," said Dr. Chatree Duangnet, Vice President and Chief Operating Officer-Medical Affairs, Bangkok Dusit Medical Services PC Ltd. (BDMS). "We are impressed with ClinicalKey's breadth and depth of medical content - from journals, medical textbooks to practice guidelines for our clinicians - all from a single online platform.  We're confident ClinicalKey can help us work smarter and more efficiently and help us improve outcomes for our patients."

"Since BDMS is an international super-tertiary hospital, the numbers of cases referred to us from other hospitals are increasing each year. This is one of the key factors that drive us to perform clinical research to find better treatment approaches. ClinicalKey provides useful and up-to-date information that help us reach our goal," said Dr. Paitoon Boonma, Director of Bangkok Health Research Center.

ClinicalKey is the world's first clinical insight engine that combines comprehensive, trusted content with the speed of revolutionary search technology to deliver fast, clinically-relevant answers. Launched in 2012, ClinicalKey draws answers from the largest proprietary collection of clinical resources, covering every medical and surgical specialty.  By combining this innovative technology with internationally accredited healthcare services, Bangkok Hospital Group is committed to be the leading healthcare provider in Southeast Asia, meeting the needs of Thai and international patients through superb care quality.

"We are proud that Bangkok Hospital Group has joined other world renowned hospitals in selecting ClinicalKey for its clinical reference needs," said Gerrit Bos, Elsevier's Managing Director, Asia Pacific.  "Combining advanced search technology with Elsevier's trusted content, we know ClinicalKey can help the doctors and researchers a part of the Bangkok Hospital Group provide the information needed for high-quality patient care and for advancing health sciences discoveries."

Hundreds of healthcare institutions - health systems, hospitals, medical schools and clinics - in more than 45 countries around the world are using ClinicalKey.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,960.57 -123.23 -0.72%
S&P 500 1,978.34 -9.64 -0.48%
NASDAQ 4,449.5640 -22.5440 -0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs